Literature DB >> 14531531

An irritable bowel syndrome-specific symptom questionnaire: development and validation.

I K Wiklund1, S Fullerton, C J Hawkey, R H Jones, G F Longstreth, E A Mayer, R A Peacock, I K Wilson, J Naesdal.   

Abstract

BACKGROUND: No self-assessment instruments are available to assess symptoms of irritable bowel syndrome (IBS). Our aim was to develop a disease-specific symptom questionnaire for use in patients with IBS.
METHODS: Two-hundred-and-thirty-four patients (77% F) with a mean age of 44 years took part in a psychometric evaluation using the previously validated Gastrointestinal Symptom Rating Scale modified for use in patients with IBS (GSRS-IBS). This version was tested against several disease-specific health-related quality of life (HRQL) questionnaires. Items with a high ceiling effect, items that measured a different construct, and items showing high correlation (>0.80) to another item were removed. A confirmatory factor analysis was also performed.
RESULTS: The final questionnaire included 13 items depicting problems with satiety, abdominal pain, diarrhoea, constipation and bloating. The internal consistency reliability was high, ranging from 0.74 (pain) to 0.85 (satiety). The associations between similar constructs in the GSRS-IBS and the various HRQL scores confirmed the construct validity. Pain, bloating and diarrhoea were the symptom clusters that impaired HRQL the most.
CONCLUSION: The GSRS-IBS is a short and user-friendly instrument with excellent psychometric properties.

Entities:  

Mesh:

Year:  2003        PMID: 14531531     DOI: 10.1080/00365520310004209

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  63 in total

1.  A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study.

Authors:  Cynthia A Thomson; Tracy E Crane; Austin Miller; David O Garcia; Karen Basen-Engquist; David S Alberts
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

Review 2.  Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.

Authors:  Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

3.  Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome.

Authors:  M Connell; A Shin; T James-Stevenson; H Xu; T F Imperiale; J Herron
Journal:  Neurogastroenterol Motil       Date:  2018-08-01       Impact factor: 3.598

4.  Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.

Authors:  Brjánn Ljótsson; Michael Jones; Nicholas J Talley; Lars Kjellström; Lars Agréus; Anna Andreasson
Journal:  United European Gastroenterol J       Date:  2020-01-14       Impact factor: 4.623

5.  Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.

Authors:  Ran Yan; Mandy Murphy; Angela Genoni; Evania Marlow; Ian C Dunican; Johnny Lo; Lesley Andrew; Amanda Devine; Claus T Christophersen
Journal:  BMJ Open Gastroenterol       Date:  2020-08

6.  Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Marianne Bonnert; Ola Olén; Maria Lalouni; Marc A Benninga; Matteo Bottai; Johanna Engelbrektsson; Erik Hedman; Fabian Lenhard; Bo Melin; Magnus Simrén; Sarah Vigerland; Eva Serlachius; Brjánn Ljótsson
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

7.  The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).

Authors:  N Kanuri; B Cassell; S E Bruce; K S White; B M Gott; C P Gyawali; G S Sayuk
Journal:  Neurogastroenterol Motil       Date:  2016-05-05       Impact factor: 3.598

8.  A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency.

Authors:  Silje F Jørgensen; Henrik M Reims; Didrik Frydenlund; Kristian Holm; Vemund Paulsen; Annika E Michelsen; Kristin K Jørgensen; Liv T Osnes; Jorunn Bratlie; Tor J Eide; Christen P Dahl; Ellen Holter; Rune R Tronstad; Kurt Hanevik; Hans-Richard Brattbakk; Fatemeh Kaveh; Torunn Fiskerstrand; Anne-Marte B Kran; Thor Ueland; Tom H Karlsen; Pål Aukrust; Knut E A Lundin; Børre Fevang
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

9.  Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

Authors:  J Labus; A Gupta; H K Gill; I Posserud; M Mayer; H Raeen; R Bolus; M Simren; B D Naliboff; E A Mayer
Journal:  Aliment Pharmacol Ther       Date:  2012-12-03       Impact factor: 8.171

10.  Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life.

Authors:  Jian-Min Si; Liang-Jing Wang; Shu-Jie Chen; Lei-Min Sun; Ning Dai
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.